Health Catalyst Soars 26.97% Despite Downgrades

On April 14, 2025, Health Catalyst's stock surged by 26.97% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Health Catalyst, Inc. (NASDAQ:HCAT) has recently faced a downgrade in its rating. Evercore ISI reduced its rating from "outperform" to "inline" in a research report released on Wednesday. This change in rating reflects a shift in the firm's outlook on the company's performance and potential for growth.

Additionally, Citigroup has also lowered their price target for Health Catalyst, indicating a more cautious stance on the stock's future prospects. These rating changes have likely contributed to the recent volatility in the stock's price, as investors reassess their positions in light of the new information.